Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Int Immunopharmacol ; 108: 108773, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35453074

ABSTRACT

Acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) is one of the leading pulmonary inflammatory disorders causing significant morbidity and mortality. Vincamine is a novel phytochemical with promising anti-inflammatory properties. In the current work, the protective effect of vincamine was studied in vitro (Raw 264.7 macrophages) and in vivo against lipopolysaccharide (LPS) induced ALI in Swiss albino mice. Vincamine significantly reduced nitrite and TNF-α release from the LPS stimulated macrophages and increased the levels of IL-10, indicating potent anti-inflammatory effects. It was observed that vincamine at the dose of 40 mg/kg, significantly reduced LPS induced inflammatory cell count in blood and in bronchoalveolar lavage (BAL) fluid. Further, vincamine exerted potent suppression of inflammation by reducing the expression of proinflammatory cytokines, while significantly increased (p < 0.001) the expression of anti-inflammatory cytokine (IL-10 and IL-22). Interestingly, histological changes were reversed in vincamine treated groups in a dose-dependent manner. Immunohistochemical analysis revealed significantly enhanced expression of NF-κB, TNF-α and COX-2 while reduced expression of Nrf-2 in disease control group, which were significantly (p < 0.001) ameliorated by vincamine. We, to the best of our knowledge, report for the first time that vincamine possesses protective potential against LPS induced inflammation and oxidative stress, possibly by inhibiting the NF-κB cascade, while positively regulating the Nrf-2 pathway. These findings are of potential relevance for COVID-19 management concerning the fact that lung injury and ARDS are its critical features.


Subject(s)
Acute Lung Injury , COVID-19 , Catharanthus , Respiratory Distress Syndrome , Vincamine , Acute Lung Injury/chemically induced , Acute Lung Injury/drug therapy , Acute Lung Injury/metabolism , Animals , Anti-Inflammatory Agents/pharmacology , Catharanthus/metabolism , Cytokines/metabolism , Inflammation/drug therapy , Interleukin-10/metabolism , Lipopolysaccharides/pharmacology , Lung/pathology , Mice , NF-kappa B/metabolism , Tumor Necrosis Factor-alpha/metabolism , Vincamine/metabolism , Vincamine/pharmacology , Vincamine/therapeutic use
2.
FASEB J ; 35(2): e21321, 2021 02.
Article in English | MEDLINE | ID: mdl-33543543

ABSTRACT

Healthy aging is associated with a decline in cognitive function, and is a major risk factor for many neurodegenerative diseases. Although, there are several evidence that brain mitochondrial function is altered with aging its significance at the cellular level is elusive. In this study, we have investigated mitochondrial TCA cycle and neurotransmitter cycle fluxes associated with glutamatergic, GABAergic neurons and astroglia in the cerebral cortex and hippocampus of young (6 months) and aged (24 months) C57BL6 mice by using 1 H-[13 C]-NMR spectroscopy together with timed infusion of 13 C-labeled glucose and acetate. The ratio VCyc /VTCA was determined from a steady-state [2-13 C]acetate experiment. Metabolic fluxes were obtained by fitting a three-compartment metabolic model to 13 C turnover of amino acids from glucose. Levels of glutamate, aspartate and taurine were reduced in the cerebral cortex, while glutamine and choline were elevated in the hippocampus of aged mice. Interestingly, the rate of acetate oxidation increased in the cerebral cortex, while the flux of mitochondrial TCA cycle of glutamatergic neurons decreased in the cerebral cortex (P < .0001) and hippocampus (P = .025) of aged mice. The glutamate-glutamine neurotransmitter cycle flux was reduced in the cerebral cortex (P < .0001). The GABAergic TCA cycle flux was reduced in the cerebral cortex (P = .0008), while GABA-glutamine neurotransmitter cycling flux was also reduced in the cerebral cortex (P = .011) and hippocampus (P = .042) of aged brain. In conclusion, the reduction in excitatory and inhibitory neurotransmitter activity of glutamatergic and GABAergic neurons in the cerebral cortex and hippocampus correlates qualitatively with declined cognitive function in aged mice.


Subject(s)
Brain/metabolism , Glutamic Acid/metabolism , Magnetic Resonance Spectroscopy/methods , gamma-Aminobutyric Acid/metabolism , Aging/physiology , Animals , Blotting, Western , Energy Metabolism/physiology , Forelimb/metabolism , Male , Mice , Mice, Inbred C57BL , Oxidation-Reduction , Rats
3.
Cell Biochem Funct ; 39(2): 296-307, 2021 Mar.
Article in English | MEDLINE | ID: mdl-32767404

ABSTRACT

Apoptosis-inducing factor (AIF) is a mitochondrial flavoprotein involved in redox signalling and programmed cell death. The role of AIF has been well recognized in diabetes and obesity. However, the aspect of AIF deficiency in the development of hepatic steatosis and liver injury is unknown. Therefore, in the current study, Harlequin (Hq mutant) mouse with markedly reduced content of AIF was investigated to explore the role of AIF on the initiation of liver injury. The wild type (WT) developed physiological and pathological features of non-alcoholic fatty liver disease (NAFLD) that were not seen in the Hq mice with AIF deficiency, when fed on high fat high fructose (HFHF) diet. Following bile duct ligation (BDL), the liver associated pathological changes were less conspicuous in Hq mice as compared to WT mice. The expression of AIF protein and apoptosis was markedly lesser as compared to their respective control in Hq mice on HFHF diet. Furthermore, the genes involved in fatty acid metabolism were also altered in the group of treated Hq mice. In conclusion, Hq mice failed to develop diet induced hepatic steatosis, suggestive of a role of AIF mediated pathway in the initiation and progression of liver inflammation. Thus, partial loss of AIF appears to be hepatoprotective. SIGNIFICANCE OF THE STUDY: AIF deficiency has multiple roles in altered pathology processes and cellular metabolism, thereby compromising the cellular homeostasis. Considering the molecular functions of AIF in other organ pathology little is known about its role in diet induced liver injury. Hence, the aim of the current study was to investigate the role of AIF deficiency in liver injury and diseases with focus on NAFLD. The study will help to deliniate the mechanisms of NAFLD using Harliquin Mice.


Subject(s)
Apoptosis Inducing Factor/metabolism , Diet, High-Fat , Non-alcoholic Fatty Liver Disease/pathology , Animals , Apoptosis Inducing Factor/deficiency , Apoptosis Inducing Factor/genetics , B-Lymphocytes/cytology , B-Lymphocytes/metabolism , Bile Ducts/surgery , Blood Glucose/analysis , Disease Models, Animal , Fatty Acid Synthases/genetics , Fatty Acid Synthases/metabolism , Liver/metabolism , Liver/pathology , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Non-alcoholic Fatty Liver Disease/metabolism , Reactive Oxygen Species/metabolism , T-Lymphocytes, Cytotoxic/cytology , T-Lymphocytes, Cytotoxic/metabolism , Triglycerides/analysis , Up-Regulation
4.
Can J Physiol Pharmacol ; 96(4): 419-427, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29053935

ABSTRACT

Alcohol, the most common cause for hepatic injury, may further deteriorate the hepatic tissue when left unattended. Capsaicin, the pungent principle of chilli peppers, possesses antioxidant and anti-inflammatory properties and is a proven dietary antioxidant in various ailments. However, its role in alcohol-induced hepatic injury is unclear. In this study, we investigated the effects of capsaicin on the hepatic tissue of mice treated with alcohol. Acute liver injury was induced in mice by oral gavage of 5 doses of 10 mL/kg of 50% ethyl alcohol at an interval of 12 h. The tissue antioxidant levels along with the mitochondrial functional parameters and matrix metalloproteinase levels were evaluated in the hepatic tissues of mice following alcohol challenge. The results showed that alcohol intake significantly attenuated the hepatic antioxidant levels and mitochondrial function. These changes were accompanied by enhanced serum hepatic injury markers and matrix metalloproteinases. However, capsaicin treatment (10 and 20 mg/kg, oral) throughout the experimental period caused a drastic improvement in the hepatic tissue of the alcohol-treated mice, reflected by the normalization of hepatic enzyme and protein levels along with restored histological alterations. These results indicate that capsaicin, as a dietary intervention, may prevent alcohol-induced acute liver injury.


Subject(s)
Capsaicin/pharmacology , Capsicum/chemistry , Ethanol/adverse effects , Liver/enzymology , Liver/injuries , Matrix Metalloproteinases/metabolism , Acute Disease , Animals , Antioxidants/metabolism , Biomarkers/metabolism , Heme Oxygenase-1/metabolism , Liver/drug effects , Liver/pathology , Male , Matrix Metalloproteinases/blood , Mice, Inbred C57BL , Mitochondria/drug effects , Mitochondria/metabolism , Nitrites/metabolism , Organ Size/drug effects , Protein Carbonylation/drug effects , Stress, Physiological/drug effects , Thiobarbituric Acid Reactive Substances/metabolism , Transcription Factor RelA/metabolism
5.
Can J Physiol Pharmacol ; 95(1): 32-42, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27901381

ABSTRACT

This study was designed to investigate the effects of fisetin (FST) on hyperhomocysteinemia (HHcy)-induced experimental endothelial dysfunction (ED) and vascular dementia (VaD) in rats. Wistar rats were randomly divided into 8 groups: control, vehicle control, l-methionine, FST (5, 10, and 25 mg/kg, p.o.), FST-per se (25 mg/kg, p.o.), and donepezil (0.1 mg/kg, p.o.). l-Methionine administration (1.7 g/kg, p.o.) for 32 days induced HHcy. ED and VaD induced by HHcy were determined by vascular reactivity measurements, behavioral analysis using Morris water maze and Y-maze, along with a biochemical and histological evaluation of thoracic aorta and brain tissues. Administration of l-methionine developed behavioral deficits; triggered brain lipid peroxidation (LPO); compromised brain acetylcholinesterase activity (AChE); and reduced the levels of brain superoxide dismutase (SOD), brain catalase (CAT), brain reduced glutathione (GSH), and serum nitrite; and increased serum homocysteine and cholesterol levels. These effects were accompanied by decreased vascular NO bioavailability, marked intimal thickening of the aorta, and multiple necrotic foci in brain cortex. HHcy-induced alterations in the activities of SOD, CAT, GSH, AChE, LPO, behavioral deficits, ED, and histological aberrations were significantly attenuated by treatment with fisetin in a dose-dependent manner. Collectively, our results indicate that fisetin exerts endothelial and neuroprotective effects against HHcy-induced ED and VaD.


Subject(s)
Dementia, Vascular/drug therapy , Endothelium, Vascular/drug effects , Flavonoids/pharmacology , Flavonoids/therapeutic use , Hyperhomocysteinemia/drug therapy , Acetylcholinesterase/metabolism , Animals , Aorta/pathology , Brain/metabolism , Catalase/metabolism , Cholesterol/blood , Dementia, Vascular/blood , Dementia, Vascular/complications , Dementia, Vascular/metabolism , Donepezil , Dose-Response Relationship, Drug , Flavonols , Glutathione/metabolism , Homocysteine/blood , Hyperhomocysteinemia/chemically induced , Hyperhomocysteinemia/complications , Hyperhomocysteinemia/metabolism , Indans/therapeutic use , Lipid Peroxidation/drug effects , Male , Maze Learning , Methionine/adverse effects , Necrosis/drug therapy , Necrosis/pathology , Nitric Oxide/metabolism , Nitrites/blood , Piperidines/therapeutic use , Rats , Superoxide Dismutase/metabolism
6.
PLoS One ; 10(7): e0134139, 2015.
Article in English | MEDLINE | ID: mdl-26222683

ABSTRACT

Acute renal failure is a serious complication of the anticancer drug cisplatin. The potential role of baicalein, a naturally occurring bioflavonoid on cisplatin-induced renal injury is unknown. Here, we assessed the effect of baicalein against a murine model of cisplatin-induced acute renal failure and investigated the underlying possible mechanisms. Renal function, kidney histology, inflammation, oxidative stress, renal mitochondrial function, proteins involved in apoptosis, nuclear translocation of Nrf2 and effects on intracellular signaling pathways such as MAPKs, and NF-κB were assessed. Pretreatment with baicalein ameliorated the cisplatin-induced renal oxidative stress, apoptosis and inflammation and improved kidney injury and function. Baicalein inhibited the cisplatin-induced expression of iNOS, TNF-α, IL-6 and mononuclear cell infiltration and concealed redox-sensitive transcription factor NF-κB activation via reduced DNA-binding activity, IκBα phosphorylation and p65 nuclear translocation in kidneys. Further studies demonstrated baicalein markedly attenuated cisplatin-induced p38 MAPK, ERK1/2 and JNK phosphorylation in kidneys. Baicalein also restored the renal antioxidants and increased the amount of total and nuclear accumulation of Nrf2 and downstream target protein, HO-1 in kidneys. Moreover, baicalein preserved mitochondrial respiratory enzyme activities and inhibited cisplatin-induced apoptosis by suppressing p53 expression, Bax/Bcl-2 imbalance, cytochrome c release and activation of caspase-9, caspase-3 and PARP. Our findings suggest that baicalein ameliorates cisplatin-induced renal damage through up-regulation of antioxidant defense mechanisms and down regulation of the MAPKs and NF-κB signaling pathways.


Subject(s)
Acute Kidney Injury/prevention & control , Antioxidants/metabolism , Down-Regulation/drug effects , Flavanones/pharmacology , Mitogen-Activated Protein Kinases/metabolism , NF-kappa B/metabolism , Up-Regulation/drug effects , Acute Kidney Injury/chemically induced , Acute Kidney Injury/metabolism , Animals , Antineoplastic Agents/adverse effects , Apoptosis/drug effects , Cisplatin/adverse effects , Flavonoids/pharmacology , Kidney/drug effects , Kidney/metabolism , Male , Mice , Mice, Inbred BALB C , Oxidative Stress/drug effects , Phosphorylation/drug effects , Signal Transduction/drug effects
7.
PLoS One ; 9(9): e105070, 2014.
Article in English | MEDLINE | ID: mdl-25184746

ABSTRACT

Nephrotoxicity is a dose-dependent side effect of cisplatin limiting its clinical usage in the field of cancer chemotherapy. Fisetin is a bioactive flavonoid with recognized antioxidant and anti-inflammatory properties. In the present study, we investigated the potential renoprotective effect and underlying mechanism of fisetin using rat model of cisplatin-induced nephrotoxicity. The elevation in serum biomarkers of renal damage (blood urea nitrogen and creatinine); degree of histopathological alterations and oxidative stress were significantly restored towards normal in fisetin treated, cisplatin challenged animals. Fisetin treatment also significantly attenuated the cisplatin-induced IκBα degradation and phosphorylation and blocked the NF-κB (p65) nuclear translocation, with subsequent elevation of pro-inflammatory cytokine, TNF-α, protein expression of iNOS and myeloperoxidase activities. Furthermore, fisetin markedly attenuated the translocation of cytochrome c protein from the mitochondria to the cytosol; decreased the expression of pro-apoptotic proteins including Bax, cleaved caspase-3, cleaved caspase-9 and p53; and prevented the decline of anti-apoptotic protein, Bcl-2. The cisplatin-induced mRNA expression of NOX2/gp91phox and NOX4/RENOX and the NADPH oxidase enzyme activity were also significantly lowered by fisetin treatment. Moreover, the evaluated mitochondrial respiratory enzyme activities and mitochondrial antioxidants were restored by fisetin treatment. Estimation of platinum concentration in kidney tissues revealed that fisetin treatment along with cisplatin did not alter the cisplatin uptake in kidney tissues. In conclusion, these findings suggest that fisetin may be used as a promising adjunct candidate for cisplatin use.


Subject(s)
Antineoplastic Agents/toxicity , Antioxidants/pharmacology , Cisplatin/toxicity , Flavonoids/pharmacology , Kidney/drug effects , Animals , Antioxidants/pharmacokinetics , Blood Urea Nitrogen , Caspase 3/genetics , Caspase 3/metabolism , Caspase 9/genetics , Caspase 9/metabolism , Cisplatin/antagonists & inhibitors , Creatinine/blood , Cytochromes c/genetics , Cytochromes c/metabolism , Flavonoids/pharmacokinetics , Flavonols , Gene Expression Regulation , I-kappa B Proteins/genetics , I-kappa B Proteins/metabolism , Kidney/metabolism , Kidney/pathology , Male , NF-KappaB Inhibitor alpha , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type II/metabolism , Peroxidase/genetics , Peroxidase/metabolism , Phosphorylation , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Rats , Rats, Sprague-Dawley , Signal Transduction , Transcription Factor RelA/genetics , Transcription Factor RelA/metabolism , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
8.
Nucleic Acids Res ; 42(2): 764-73, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24157835

ABSTRACT

Building molecular correlates of drug resistance in cancer and exploiting them for therapeutic intervention remains a pressing clinical need. To identify factors that impact drug resistance herein we built a model that couples inherent cell-based response toward drugs with transcriptomes of resistant/sensitive cells. To test this model, we focused on a group of genes called metastasis suppressor genes (MSGs) that influence aggressiveness and metastatic potential of cancers. Interestingly, modeling of 84 000 drug response transcriptome combinations predicted multiple MSGs to be associated with resistance of different cell types and drugs. As a case study, on inducing MSG levels in a drug resistant breast cancer line resistance to anticancer drugs caerulomycin, camptothecin and topotecan decreased by more than 50-60%, in both culture conditions and also in tumors generated in mice, in contrast to control un-induced cells. To our knowledge, this is the first demonstration of engineered reversal of drug resistance in cancer cells based on a model that exploits inherent cellular response profiles.


Subject(s)
Drug Resistance, Neoplasm/genetics , Genes, Tumor Suppressor , Neoplasms/genetics , Cell Engineering , Cell Line, Tumor , Epithelial Cells/metabolism , Gene Expression Profiling , Humans , Mesoderm/metabolism , Neoplasm Metastasis , Neoplasms/metabolism
9.
Chempluschem ; 79(4): 610-618, 2014 Apr.
Article in English | MEDLINE | ID: mdl-31986703

ABSTRACT

Two hexacationic pentamethylcyclopentadienyl rhodium(III) and iridium(III) metalla-prisms, [(η5 -C5 Me5 )6 M6 (µ3 -tpt-κN)2 (µ4 -C6 HRO4 -κO)3 ]6+ (tpt=2,4,6-tri-(pyridin-4-yl)-1,3,5-triazine; R=(CH2 )10 CH3 ; M=Rh, [3]6+ ; M=Ir, [4]6+ ) isolated as their triflate salts, have been synthesised from the dinuclear complexes (η5 -C5 Me5 )2 M2 (µ4 -C6 HRO4 -κO)Cl2 (M=Rh, 1; M=Ir, 2) and AgCF3 SO3 . The antiproliferative activity of the neutral and cationic complexes has been evaluated in vitro in human cancer cell lines. The positively charged metalla-prisms appear to target mitochondria, which ultimately induce apoptosis in cancer cells. All biological studies suggest that the rhodium derivative [3][CF3 SO3 ]6 possesses excellent activities, not only in vitro but also in vivo in tumour-induced C57L6/J mice.

10.
PLoS One ; 8(8): e70798, 2013.
Article in English | MEDLINE | ID: mdl-23976957

ABSTRACT

Triazoles are known for their non-toxicity, higher stability and therapeutic activity. Few nucleoside (L1, L2 and L3) and non-nucleoside 1,2,3-triazoles (L4-L14) were synthesised using click chemistry and they were screened for tumor cell cytotoxicity and proliferation. Among these triazole ligands studied, nucleoside ligands exhibited higher potential than non-nucleoside ligands. The nucleoside triazole analogues, 3'-Phenyl-1,2,3- triazole-thymidine (L2) and 3'-4-Chlorophenyl-1,2,3-triazole-thymidine (L3), demonstrated higher cytotoxicity in tumor cells than in normal cells. The IC50 value for L3 was lowest (50 µM) among the ligands studied. L3 terminated cell cycle at S, G2/M phases and enhanced sub-G1 populations, manifesting induction of apoptosis in tumor cells. Confocal studies indicated that nucleoside triazole ligands (L2/L3) cause higher DNA fragmentation than other ligands. Preclinical experiments with tumor-induced mice showed greater reduction in tumor size with L3. In vitro DNA synthesis reaction with L3 exhibited higher DNA synthesis inhibition with quadruplex forming DNA (QF DNA) than non quadruplex forming DNA (NQF DNA). T(m) of quadruplex DNA increased in the presence of L3, indicating its ability to enhance stability of quadruplex DNA at elevated temperature and the results indicate that it had higher affinity towards quadruplex DNA than the other forms of DNA (like dsDNA and ssDNA). From western blot experiment, it was noticed that telomerase expression levels in the tissues of tumor-induced mice were found to be reduced on L3 treatment. Microcalorimetry results emphasise that two nucleoside triazole ligands (L2/L3) interact with quadruplex DNA with significantly higher affinity (K(d)≈10⁻7 M). Interestingly the addition of an electronegative moiety to the phenyl group of L2 enhanced its anti-proliferative activity. Though IC50 values are not significantly low with L3, the studies on series of synthetic 1,2,3-triazole ligands are useful for improving and building potential pro-apoptotic ligands.


Subject(s)
Antineoplastic Agents/pharmacology , DNA, Neoplasm/antagonists & inhibitors , G-Quadruplexes/drug effects , Melanoma, Experimental/drug therapy , Skin Neoplasms/drug therapy , Thymidine/chemistry , Triazoles/chemistry , Animals , Antineoplastic Agents/chemical synthesis , Cell Line, Tumor , Cell Proliferation/drug effects , Click Chemistry , DNA Fragmentation/drug effects , DNA, Neoplasm/biosynthesis , Humans , Ligands , Melanoma, Experimental/chemistry , Melanoma, Experimental/pathology , Mice , Mice, Inbred C57BL , Skin Neoplasms/chemistry , Skin Neoplasms/pathology , Tumor Burden/drug effects , Zidovudine/chemistry
11.
J Thromb Thrombolysis ; 36(3): 277-85, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23117547

ABSTRACT

Antioxidants are widely used for prevention of diseases associated with oxidative stress and ischemic disorder. We investigated the hypothesis of antioxidants (α-tocopherol and ß-carotene) can suppress the renal disorder in apo E-/-mice. Renal damage induced by chronic infusion of Angiotensin II (Ang II) into 4 month old male apo E-/-mice. After that the mice were treated with diet enriched α tocopherol and ß carotene (800 mg/kg) for 150 days. Ang II treated kidney showed polycystic appearance with accumulation of clear fluid and constriction of renal artery and renal vein was noticed. Vacuolar/cystic degeneration as well as inflammatory reactions was noticed in the tubules/glomerulus of Ang II treated mice. ß carotene treated mice showed enormous numbers of regenerated tubules in the kidney and over expression of ICAM proteins in the regenerated tubules. CD 45.2, MAC 3 proteins were over expressed in the inflammatory cells infiltrated into the tubular region of Ang II treated kidney. Gene expression studies revealed up regulation of Renin 1 (Ren 1) and PPARγ genes in the kidney of Ang II treated animals, but the ß carotene treatment controlled the expression of these genes in the regenerated kidneys. ß carotene may have protective effective on chronic renal disorder. It may repress the inflammatory genes (Ren 1, PPARγ) to achieve the protective effect on Ang II induced renal damage.


Subject(s)
Angiotensin II/adverse effects , Cell Movement/drug effects , PPAR gamma/metabolism , Renal Insufficiency, Chronic/metabolism , Renin/metabolism , beta Carotene/pharmacology , Angiotensin II/genetics , Angiotensin II/pharmacology , Animals , Apolipoproteins E/genetics , Apolipoproteins E/metabolism , Female , Inflammation/chemically induced , Inflammation/genetics , Inflammation/metabolism , Inflammation/pathology , Kidney Glomerulus/injuries , Kidney Glomerulus/metabolism , Kidney Glomerulus/pathology , Kidney Tubules, Proximal/injuries , Kidney Tubules, Proximal/metabolism , Kidney Tubules, Proximal/pathology , Male , Mice , Mice, Knockout , PPAR gamma/genetics , Polycystic Kidney Diseases/chemically induced , Polycystic Kidney Diseases/genetics , Polycystic Kidney Diseases/metabolism , Polycystic Kidney Diseases/pathology , Renal Insufficiency, Chronic/chemically induced , Renal Insufficiency, Chronic/genetics , Renal Insufficiency, Chronic/pathology , Renin/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...